Suven Life Sciences Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
2335.57 Cr.
|
P/BV
|
4.71
|
Book Value (Rs.)
|
22.74
|
52 Week High/Low (Rs.)
|
129/55
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
Bookclosure
|
05/08/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | -6.63 | -9.57 | -5.67 | -7.40 | -1.88 |
Diluted EPS (Rs.) | -6.63 | -9.57 | -5.67 | -7.40 | -1.88 |
Cash EPS (Rs.) | -5.12 | -8.09 | -5.33 | -7.07 | -1.03 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 17.21 | 6.61 | 8.49 | 11.26 | 18.79 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 17.21 | 6.61 | 8.49 | 11.26 | 18.79 |
Revenue From Operations / Share (Rs.) | 0.62 | 0.81 | 1.06 | 1.13 | 22.44 |
PBDIT / Share (Rs.) | -5.39 | -8.05 | -5.68 | -7.99 | 1.01 |
PBIT / Share (Rs.) | -5.69 | -8.35 | -6.02 | -8.32 | 0.16 |
PBT / Share (Rs.) | -5.42 | -8.39 | -6.09 | -8.36 | 0.01 |
Net Profit / Share (Rs.) | -5.42 | -8.39 | -5.67 | -7.40 | -1.88 |
NP After MI And SOA / Share (Rs.) | -5.42 | -8.39 | -5.67 | -7.40 | -1.88 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | -867.37 | -988.42 | -536.50 | -705.39 | 4.50 |
PBIT Margin (%) | -915.70 | -1025.51 | -568.75 | -734.31 | 0.72 |
PBT Margin (%) | -873.52 | -1029.98 | -574.80 | -738.14 | 0.05 |
Net Profit Margin (%) | -873.52 | -1029.98 | -535.31 | -653.62 | -8.36 |
NP After MI And SOA Margin (%) | -873.52 | -1029.98 | -535.31 | -653.62 | -8.36 |
Return on Networth / Equity (%) | -31.51 | -126.88 | -66.80 | -65.72 | -9.99 |
Return on Capital Employeed (%) | -32.81 | -121.80 | -68.13 | -68.10 | 0.78 |
Return On Assets (%) | -30.41 | -112.92 | -56.18 | -51.78 | -7.87 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Total Debt / Equity (X) | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 |
Asset Turnover Ratio (%) | 0.02 | 0.03 | 0.04 | 0.04 | 0.42 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 22.61 | 8.01 | 6.45 | 2.49 | 7.07 |
Quick Ratio (X) | 22.61 | 8.01 | 6.45 | 2.49 | 7.07 |
Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 1.14 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | -406.21 | -220.85 | -88.68 | -184.40 | 6.72 |
Interest Coverage Ratio (Post Tax) (%) | -428.84 | -229.14 | -87.49 | -169.87 | -11.49 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 872.72 | 1343.38 | 849.81 | 258.38 | 3321.88 |
EV / Net Operating Revenue (X) | 64.46 | 113.42 | 63.05 | 17.92 | 11.63 |
EV / EBITDA (X) | -7.43 | -11.47 | -11.75 | -2.54 | 258.33 |
MarketCap / Net Operating Revenue (X) | 78.07 | 113.85 | 66.48 | 18.90 | 11.62 |
Price / BV (X) | 2.82 | 14.02 | 8.30 | 1.90 | 13.89 |
Price / Net Operating Revenue (X) | 78.08 | 113.85 | 66.48 | 18.90 | 11.62 |
EarningsYield | -0.11 | -0.09 | -0.08 | -0.34 | -0.01 |